SF3B1 mutations are known to contribute to tumor pathogenesis by disrupting various cellular functions and pathways, including heme biosynthesis, mitochondrial metabolism, and the NF-κB pathway [24]. The gene discussed is NFKB1; the disease is neoplasm.